Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04271722
Other study ID # 2020OBST1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2020
Est. completion date December 30, 2022

Study information

Verified date May 2024
Source Centro Hospitalar Lisboa Norte
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized controlled trial of mifepristone 200mg vs balloon catheter for cervical ripening.


Description:

Artificial induction of labour is currently required in 25-30% of all pregnancies, in high-resource countries. While the pharmacological modifications to the collagen matrix of the cervix, that allow it to dilate (cervical ripening) occur spontaneously in many women, allowing labour to be induced with oxytocin, in others the process needs to be triggered artificially. Cervical ripening is traditionally accomplished with prostaglandins or mechanical agents, in processes that typically require 12-24 hours of hospital stay. More recently, a limited number of hospitals have shifted towards starting the process in house, but then allowing women to return home and be re-evaluated on the following day. The main aims this study is to compare efficacy and patient satisfaction of mifepristone vs balloon catheter for cervical ripening.


Recruitment information / eligibility

Status Completed
Enrollment 101
Est. completion date December 30, 2022
Est. primary completion date December 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Pregnant woman scheduled for induction of labor. - Age between 18 and 45 years. - Understanding and capable to sign informed consent. - Singleton pregnancy. - Gestational age = 37 0/7 weeks. - Live fetus in cephalic presentation. - Intact membranes - Bishop score < 6 - Estimated fetal weight < 4500g - Without contraindication to vaginal delivery - No major fetal anomaly Exclusion Criteria: - Previous cesarean section or myomectomy - Hypertension - Diabetes - Thyroid disease - Maternal conditions with high risk of placental insufficiency

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cervical ripening
Subjects will undergo cervical ripening in the outpatient setting. The patients will then be scheduled to return the next morning for induction of labor.

Locations

Country Name City State
Portugal Centro Hospitalar Lisboa Norte Lisboa

Sponsors (1)

Lead Sponsor Collaborator
Centro Hospitalar Lisboa Norte

Country where clinical trial is conducted

Portugal, 

References & Publications (10)

Baev OR, Rumyantseva VP, Tysyachnyu OV, Kozlova OA, Sukhikh GT. Outcomes of mifepristone usage for cervical ripening and induction of labour in full-term pregnancy. Randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2017 Oct;217:144-149. doi: 10.1016/j.ejogrb.2017.08.038. Epub 2017 Sep 1. — View Citation

Ceccaldi PF, Saada J, Nicolas M, Ducarme G, Blot P, Guibourdenche J, Luton D. Modulation of free corticotrophin-releasing hormone, adrenal and placental steroid hormone levels induced by mifepristone during pregnancy. Fetal Diagn Ther. 2012;32(4):267-70. doi: 10.1159/000338927. Epub 2012 Jul 4. — View Citation

Diederen M, Gommers J, Wilkinson C, Turnbull D, Mol B. Safety of the balloon catheter for cervical ripening in outpatient care: complications during the period from insertion to expulsion of a balloon catheter in the process of labour induction: a systematic review. BJOG. 2018 Aug;125(9):1086-1095. doi: 10.1111/1471-0528.15047. Epub 2018 Jan 10. — View Citation

Elliott CL, Brennand JE, Calder AA. The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol. 1998 Nov;92(5):804-9. doi: 10.1016/s0029-7844(98)00284-1. — View Citation

Heikinheimo O, Kekkonen R, Lahteenmaki P. The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action. Contraception. 2003 Dec;68(6):421-6. doi: 10.1016/s0010-7824(03)00077-5. — View Citation

Rodger MW, Baird DT. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol. 1990 Jan;97(1):41-5. doi: 10.1111/j.1471-0528.1990.tb01714.x. — View Citation

Smith R, Smith JI, Shen X, Engel PJ, Bowman ME, McGrath SA, Bisits AM, McElduff P, Giles WB, Smith DW. Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J Clin Endocrinol Metab. 2009 Jun;94(6):2066-74. doi: 10.1210/jc.2008-2257. Epub 2009 Mar 3. — View Citation

Urquhart DR, Bahzad C, Templeton AA. Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination of pregnancy. Hum Reprod. 1989 Feb;4(2):202-3. doi: 10.1093/oxfordjournals.humrep.a136872. — View Citation

Vogel JP, Osoti AO, Kelly AJ, Livio S, Norman JE, Alfirevic Z. Pharmacological and mechanical interventions for labour induction in outpatient settings. Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD007701. doi: 10.1002/14651858.CD007701.pub3. — View Citation

Yelikar K, Deshpande S, Deshpande R, Lone D. Safety and Efficacy of Oral Mifepristone in Pre-induction Cervical Ripening and Induction of Labour in Prolonged Pregnancy. J Obstet Gynaecol India. 2015 Jul;65(4):221-5. doi: 10.1007/s13224-014-0584-6. Epub 2014 Jul 11. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Neonatal Intensive Care Unit admission Rate of newborns admitted in Neonatal Intensive Care Unit (%) 1-30 days
Other Postpartum haemorrhage Rate of women with postpartum haemorrhage (%) 1-7 days
Other 5 minute apgar score <7 Rate of newborns with 5 minute apgar score <7 (%) 1-4 days
Other Metabolic acidosis(pH< 7.00 e BD > 12 mmol/l) Rate of metabolic acidosis (pH< 7.00 e BD > 12 mmol/l) (%) 1-4 days
Other Neonatal mortality Rate of neonatal mortality (%) 1-7days
Primary Number of Participants with Bishop score =6 or spontaneous labour Proportion of patients (%) with Bishop score =6 or spontaneous labour 24 hours after intervention 24 hours
Secondary Mean of gain in Bishop score Mean of gain in Bishop score from intervention to hospital admission 24 hours
Secondary Time frame between intervention and active phase of labour Time frame between intervention and active phase of labour (min) 1-2 days
Secondary Time of Vaginal Delivery Delivery time frame in mins from intervention 2-4days
Secondary Number of Participants with vaginal delivery within 24hrs Rate of vaginal deliveries within 24 hours since admission to hospital (%) 1-2days
Secondary Vaginal delivery within 48hrs Rate of vaginal deliveries within 48 hours since admission to hospital (%) 1-2days
Secondary Pharmacological agents for labor induction (Prostaglandins, Oxytocin) Rate of women that required pharmacological cervical ripening agents (%) requirement (%) 1-2days
Secondary Operative deliveries Proportion of patients that delivered vaginal by forceps assistance or vacuum (%) assistance. 1-4days
Secondary Cesarean deliveries Proportion of patients that delivered by cesarean (%). 1-4days
Secondary Analgesia requirement Rate of women who require any analgesia during cervical ripening process (%) 24 hours
Secondary Vaginal bleeding Rate of women who had vaginal bleeding during cervical ripening process (%) 24 hours
Secondary Reduced fetal movements Rate of women who had reduced fetal movements during cervical ripening process (%) 24 hours
Secondary Non reassuring fetal status Rate of women who had non reassuring fetal status(CTG) during cervical ripening process (%) 24 hours
Secondary Patient Satisfaction: questionnaire Patient satisfaction associated with intervention used for cervical ripening from patient questionnaire 1-4days
See also
  Status Clinical Trial Phase
Completed NCT06343480 - Misoprostol Versus Oxytocin for Induction of Labour in Parturients With Spontaneous Rupture of Fetal Membranes at Term N/A
Not yet recruiting NCT03985618 - The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity N/A
Not yet recruiting NCT05510310 - Breast Stimulation vs. Low Dose Oxytocin Augmentation for Labor Induction Phase 1/Phase 2
Completed NCT06151925 - Laminaria Tents Versus Vaginal Prostaglandin in Cervical Ripening N/A
Completed NCT05084326 - Engagement of Fetal Head as a Predictor of a Successful Vaginal Delivery in Primigravidas Presented in Early Labor.
Completed NCT03670836 - Comparison of Misoprostol Ripening Efficacy With Dilapan Phase 4
Terminated NCT04564196 - Breath Metabolomics in the Laboring Parturient
Completed NCT04000438 - Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix Phase 2
Completed NCT05262738 - Misoprostol Dosing in BMI Greater Than 30 Phase 4
Withdrawn NCT05255263 - Goal-directed Labor Epidural Analgesia Maintenance N/A
Recruiting NCT05489315 - Quantifying the Impact of the Peanut Ball on the Duration of the Active Stage of Labor N/A
Not yet recruiting NCT05791630 - The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) N/A
Completed NCT04933708 - LaPPS: Labor Podcast for Patient Satisfaction N/A
Not yet recruiting NCT03784092 - Effect Mobility During Induction of Labor on Time to Delivery. A Randomized Controlled Trial N/A
Recruiting NCT06164613 - Use of Cinnamomum Verum for Induction of Labor. Double Blind Randomized Clinical Trial Phase 2
Terminated NCT04504682 - Ambulation With Labor Epidural in Obese Women N/A